Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Leases: 2019-2024

Historic Current Leases for Fortress Biotech (FBIO) over the last 6 years, with Dec 2024 value amounting to $2.6 million.

  • Fortress Biotech's Current Leases fell 15.31% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 15.31%. This contributed to the annual value of $2.6 million for FY2024, which is 3.96% up from last year.
  • As of FY2024, Fortress Biotech's Current Leases stood at $2.6 million, which was up 3.96% from $2.5 million recorded in FY2023.
  • Fortress Biotech's Current Leases' 5-year high stood at $2.6 million during FY2024, with a 5-year trough of $1.8 million in FY2020.
  • Over the past 3 years, Fortress Biotech's median Current Leases value was $2.5 million (recorded in 2023), while the average stood at $2.5 million.
  • Data for Fortress Biotech's Current Leases shows a peak YoY grew of 16.30% (in 2022) over the last 5 years.
  • Fortress Biotech's Current Leases (Yearly) stood at $1.8 million in 2020, then climbed by 13.79% to $2.1 million in 2021, then grew by 16.30% to $2.4 million in 2022, then climbed by 3.11% to $2.5 million in 2023, then increased by 3.96% to $2.6 million in 2024.